Format

Send to

Choose Destination
JAMA. 2019 Jul 16;322(3):267-269. doi: 10.1001/jama.2019.7521.

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017.

Author information

1
Harvard Medical School, Boston, Massachusetts.
2
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
3
National Bureau of Economic Research, Boston, Massachusetts.
4
University of North Carolina at Chapel Hill.
5
Brigham and Women's Hospital, Boston, Massachusetts.
PMID:
31310287
PMCID:
PMC6635901
[Available on 2020-01-16]
DOI:
10.1001/jama.2019.7521
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center